Advances in antiplatelet therapy

Keyphrases

• Cardiovascular Disease 100%
• Platelets 100%
• Antiplatelet Therapy 100%
• Coronary Artery Disease 50%
• Pathophysiology 50%
• Clinical Trials 50%
• Vascular Inflammation 50%
• Clinical High Risk 50%
• Thrombosis 50%
• Platelet Aggregation 50%
• Pharmacogenomics 50%
• Hemostasis 50%
• Novel Therapies 50%
• Therapeutic Target 50%
• Targeted Therapy 50%
• Peripheral Arterial Disease 50%
• Clinical Expression 50%
• Polypharmacy 50%
• Platelet Adhesion 50%
• Active Role 50%
• Platelet Activation 50%
• Antiplatelet Agents 50%
• Patients with Cardiovascular Diseases 50%
• Western World 50%
• First-line Therapy 50%
• Antiplatelet 50%
• Incremental Benefits 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiplatelet 100%
• Cardiovascular Disease 100%
• Disease 66%
• Clinical Trial 33%
• Pathophysiology 33%
• Atherosclerosis 33%
• Vasculitis 33%
• Coronary Artery Disease 33%
• Thrombosis 33%
• Pharmacogenomics 33%
• Blood Stasis 33%
• Polypharmacy 33%
• Antithrombocytic Agent 33%
• Peripheral Occlusive Artery Disease 33%
• Cerebrovascular Accident 33%